Search research articles
Contact Us
Filters
Showing results (41-50 of 203) with videos related to
Page
of 21
Sort By:
Alimentary Pharmacology & Therapeutics
|
April 1, 2022
Editorial: is there a role for monitoring intermediate anti-TNF drug concentrations in IBD?
Shana Rakowsky, Adam S Cheifetz, Konstantinos Papamichael
Journal of Clinical Medicine
|
November 25, 2023
Drug Clearance in Patients with Inflammatory Bowel Disease Treated with Biologics
Tina Deyhim, Adam S Cheifetz, Konstantinos Papamichael
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 13, 2017
Reply
Konstantinos Papamichael, Mark T Osterman, Adam S Cheifetz
JAMA
|
September 21, 2021
Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction in Patients With Chronic Immune-Mediated Inflammatory Diseases
Konstantinos Papamichael, Marla C Dubinsky, Adam S Cheifetz
Inflammatory Bowel Diseases
|
March 22, 2012
Varicella zoster virus infection in inflammatory bowel disease
Garret Cullen, Rachel P Baden, Adam S Cheifetz
Current Treatment Options in Gastroenterology
|
January 8, 2014
The role of mucosal healing in the treatment of patients with inflammatory bowel disease
Byron P Vaughn, Sveta Shah, Adam S Cheifetz
Gastroenterology
|
April 18, 2022
Proactive Therapeutic Drug Monitoring of Adalimumab in Patients With Crohn's Disease
Konstantinos Papamichael, Marla C Dubinsky, Adam S Cheifetz
The American Journal of Gastroenterology
|
January 8, 2011
Vaccination in inflammatory bowel disease
Garret Cullen, Rachel P Baden, Adam S Cheifetz
Gastroenterology Clinics of North America
|
May 20, 2022
Therapeutic Drug Monitoring of Biologics in Crohn's Disease
Laurie B Grossberg, Adam S Cheifetz, Konstantinos Papamichael
Gut
|
February 21, 2020
New role for azathioprine in case of switching anti-TNFs in IBD
Konstantinos Papamichael, Adam S Cheifetz, Peter M Irving
Page
of 21
Search research articles
Search
Showing results (41-50 of 203) with videos related to
Sort By:
Page
of 21
Alimentary Pharmacology & Therapeutics
|
April 1, 2022
Editorial: is there a role for monitoring intermediate anti-TNF drug concentrations in IBD?
Shana Rakowsky, Adam S Cheifetz, Konstantinos Papamichael
Journal of Clinical Medicine
|
November 25, 2023
Drug Clearance in Patients with Inflammatory Bowel Disease Treated with Biologics
Tina Deyhim, Adam S Cheifetz, Konstantinos Papamichael
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 13, 2017
Reply
Konstantinos Papamichael, Mark T Osterman, Adam S Cheifetz
JAMA
|
September 21, 2021
Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction in Patients With Chronic Immune-Mediated Inflammatory Diseases
Konstantinos Papamichael, Marla C Dubinsky, Adam S Cheifetz
Inflammatory Bowel Diseases
|
March 22, 2012
Varicella zoster virus infection in inflammatory bowel disease
Garret Cullen, Rachel P Baden, Adam S Cheifetz
Current Treatment Options in Gastroenterology
|
January 8, 2014
The role of mucosal healing in the treatment of patients with inflammatory bowel disease
Byron P Vaughn, Sveta Shah, Adam S Cheifetz
Gastroenterology
|
April 18, 2022
Proactive Therapeutic Drug Monitoring of Adalimumab in Patients With Crohn's Disease
Konstantinos Papamichael, Marla C Dubinsky, Adam S Cheifetz
The American Journal of Gastroenterology
|
January 8, 2011
Vaccination in inflammatory bowel disease
Garret Cullen, Rachel P Baden, Adam S Cheifetz
Gastroenterology Clinics of North America
|
May 20, 2022
Therapeutic Drug Monitoring of Biologics in Crohn's Disease
Laurie B Grossberg, Adam S Cheifetz, Konstantinos Papamichael
Gut
|
February 21, 2020
New role for azathioprine in case of switching anti-TNFs in IBD
Konstantinos Papamichael, Adam S Cheifetz, Peter M Irving
Page
of 21